Verdict
Pros
- $99/mo for the oral lozenge on auto-refill. Strut requires documented medical necessity for the lozenge. Injectable semaglutide starts at $149/mo.
- $149/mo for injectable semaglutide has not moved across 10 weekly price checks since June 2026.
- No membership fee. Consults and shipping are included in the price.
- A sublingual lozenge for patients who cannot use an injection.
- Three days to first prescription. Async intake, no video visit and no labs.
- Cancel auto-refill anytime, no upfront commitment.
Cons
- Lozenge bioavailability data is thin compared to standard injectable semaglutide.
- No insurance integration, cash-pay only.
- Not available in Louisiana or Mississippi.
Cost-sensitive patients who want needle-free GLP-1 entry under $100/mo and don't mind a less-studied delivery format.
Anyone who wants brand-name FDA-approved semaglutide or insurance-billed care.
Pricing
Oral lozenge from $99/mo; injectable semaglutide from $149/mo (both auto-refill). No membership, consult and shipping included. Maintenance doses may escalate.
| Signup / one-time | None |
| Membership / subscription | None |
| Medication (varies by dose) | $99–$349/mo |
| All-in, lowest maintenance dose | $149/mo |
Price since we started tracking
$149/mo, held flat across 11 weekly checks since May 2026. See the full price tracker.
See how Strut Health compares with every path in our GLP-1 cost guide, or check the live price index for the full chart.
Lock-in & cancellation
Month-to-month
Cancel auto-refill anytime; no upfront commitment required.
Medication options
US-licensed compounding pharmacies with FDA-licensed ingredient sources. Compounded products are not FDA-approved for safety or efficacy.
A licensed US pharmacy makes compounded semaglutide and tirzepatide to a prescription. They are not FDA-approved and they are not Wegovy, Ozempic, Zepbound or Mounjaro. The FDA does not review them for safety, effectiveness or quality, and their formulation, including the salt form, can differ from the approved drug. Confirm the active ingredient and the pharmacy with the prescriber. The FDA removed semaglutide from the drug-shortage list in February 2025, which narrowed the legal basis for routine 503A compounding of exact-copy semaglutide. Strut Health uses a personalized-formulation model: the compound adds an active ingredient such as vitamin B12. Some state pharmacy boards tightened oversight through 2025 and 2026. For the full background see our compounded vs FDA-approved breakdown.
FDA-approved branded
- None offered
Compounded
- Sublingual semaglutide lozenges
- Injectable compounded semaglutide
- Injectable compounded tirzepatide
Other medications
- None offered
Read the buyer's guide for the medications Strut Health covers: compounded semaglutide, compounded tirzepatide.
The drug comparison table covers semaglutide vs tirzepatide on cost, side effects, and clinical evidence side by side.
Where it's compounded
| Pharmacy | Not publicly disclosed |
| Regulatory model | 503A (state-licensed, patient-specific prescriptions) |
| Accreditation | Claims a 'PCAB-accredited partner' but does not name the pharmacy |
| Disclosure | Not publicly disclosed |
Strut Health does not publicly name the pharmacy that compounds its GLP-1 medications. This is a transparency gap, not a statement about medication safety. Questions worth asking any program: is the pharmacy a named 503A or 503B facility, is it US-licensed, does it carry independent accreditation (PCAB, NABP), and does it provide sterility and potency testing results on request?
Strut does not name its compounding pharmacy.
For background on 503A vs 503B regulation and how to vet a compounding pharmacy, see Which pharmacy compounds your GLP-1, and why it matters.
Onboarding experience
Time to first prescription: 3 days.
Consultation type: Async questionnaire reviewed by US-licensed physician.
Requirements: Health history, weight, no in-person visit needed.
Strut Health reviews: what members report
Solid niche program with the most affordable cash-pay compounded entry in the category. Format trade-off is real.
What works
- Lowest entry price for compounded semaglutide
- Convenient lozenge format
- Transparent flat pricing
What to watch
- Lozenge weight loss results lag injection in anecdotal reports
- Limited customer service hours
- No insurance integration
How we scored Strut Health
Five dimensions, ten points each, weighted equally. Overall is the simple average.
Transparency
Terms
Experience
Options
Reviews
The member-reviews pillar reflects Strut Health’s Trustpilot rating of 3.4/5. See it on Trustpilot →
Frequently asked questions
Is Strut Health legit?
Is Strut Health a scam?
Are the sublingual lozenges as effective as injections?
Is there a membership fee?
Can I use HSA/FSA?
Partner programs
If Strut Health isn't the right fit, here are three programs to consider next:
These programs pay GLP Chart a commission when you join. Disclosure
Before committing to a cash-pay path, check whether your insurance covers a GLP-1 at the payer coverage center. On Medicaid, see Medicaid GLP-1 coverage by state first. If you need PA paperwork, the prior authorization letter library has templates for all major plans. Already denied? The appeal letter library has 120 templates by denial reason.
Learn the category before you commit
Read these before signing up for any GLP-1 telehealth program, Strut Health included:
The FDA sent Strut Health a warning letter on February 20, 2026, citing misbranded compounded semaglutide and tirzepatide. The FDA has not published a close-out letter. Source: FDA
